RenovoRx, Inc. Common Stock
Symbol: RNXT (NASDAQ)
1.16
▼ (-1.28%) -0.015
Company Description:
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Key Stats
- Today's Open: $1.15
- Today's High: $1.175
- Today's Low: $1.115
- Today's Volume: 309.71K
- Yesterday Close: $1.17
- Yesterday High: $1.3
- Yesterday Low: $1.14
- Yesterday Volume: 763.02K
- Last Min Volume: 250
- Last Min High: $1.155
- Last Min Low: $1.155
- Last Min VWAP: $1.155
Company Profile
- Name: RenovoRx, Inc. Common Stock
- Website: https://www.renovorx.com
- Listed Date: 2021-08-26
- Location: MOUNTAIN VIEW, CA
- Market Status: Active
- CIK Number: 0001574094
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $41.04M
- Round Lot: 100
- Outstanding Shares: 36.65M
- Asset Type: CS
RECENT FILINGS FOR RNXT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-03 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-08-26 | 4 | View |
| 2025-08-14 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-06-27 | S-8 | View |
| 2025-06-25 | 8-K | View |
| 2025-06-09 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-15 | 8-K | View |
| 2025-05-08 | SCHEDULE 13G | View |
| 2025-05-07 | SCHEDULE 13G | View |
Latest News on RNXT